Gansevoort RT, Wheeler DC, Deben FM, Speeckaert M, et al. The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial. Nephrol Dial Transplant 2024 Dec 3:gfae261. doi: 10.1093.
PMID: 39656628